Literature DB >> 30817143

Mutagenic Replication of the Major Oxidative Adenine Lesion 7,8-Dihydro-8-oxoadenine by Human DNA Polymerases.

Myong-Chul Koag1, Hunmin Jung1, Seongmin Lee1.   

Abstract

Reactive oxygen species attack DNA to produce 7,8-dihyro-8-oxoguanine (oxoG) and 7,8-dihydro-8-oxoadenine (oxoA) as major lesions. The structural basis for the mutagenicity of oxoG, which induces G to T mutations, is well understood. However, the structural basis for the mutagenic potential of oxoA, which induces A to C mutations, remains poorly understood. To gain insight into oxoA-induced mutagenesis, we conducted kinetic studies of human DNA polymerases β and η replicating across oxoA and structural studies of polβ incorporating dTTP/dGTP opposite oxoA. While polη readily bypassed oxoA, it incorporated dGTP opposite oxoA with a catalytic specificity comparable to that of correct insertion, underscoring the promutagenic nature of the major oxidative adenine lesion. Polη and polβ incorporated dGTP opposite oxoA ∼170-fold and ∼100-fold more efficiently than that opposite dA, respectively, indicating that the 8-oxo moiety greatly facilitated error-prone replication. Crystal structures of polβ showed that, when paired with an incoming dTTP, the templating oxoA adopted an anti conformation and formed Watson-Crick base pair. When paired with dGTP, oxoA adopted a syn conformation and formed a Hoogsteen base pair with Watson-Crick-like geometry, highlighting the dual-coding potential of oxoA. The templating oxoA was stabilized by Lys280-mediated stacking and hydrogen bonds. Overall, these results provide insight into the mutagenic potential and dual-coding nature of the major oxidative adenine lesion.

Entities:  

Year:  2019        PMID: 30817143      PMCID: PMC6657779          DOI: 10.1021/jacs.8b08551

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  85 in total

1.  Single 8-oxo-guanine and 8-oxo-adenine lesions induce marked changes in the backbone structure of a 25-base DNA strand.

Authors:  D C Malins; N L Polissar; G K Ostrander; M A Vinson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase eta.

Authors:  L Haracska; S L Yu; R E Johnson; L Prakash; S Prakash
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

3.  Comparison of the mutagenic properties of 8-oxo-7,8-dihydro-2'-deoxyadenosine and 8-oxo-7,8-dihydro-2'-deoxyguanosine DNA lesions in mammalian cells.

Authors:  X Tan; A P Grollman; S Shibutani
Journal:  Carcinogenesis       Date:  1999-12       Impact factor: 4.944

4.  The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta.

Authors:  A Vaisman; S G Chaney
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

5.  Selective blockage of the 3'-->5' exonuclease activity of WRN protein by certain oxidative modifications and bulky lesions in DNA.

Authors:  A Machwe; R Ganunis; V A Bohr; D K Orren
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

6.  DNA polymerase beta expression differences in selected human tumors and cell lines.

Authors:  D K Srivastava; I Husain; C L Arteaga; S H Wilson
Journal:  Carcinogenesis       Date:  1999-06       Impact factor: 4.944

7.  Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells.

Authors:  Y Canitrot; J S Hoffmann; P Calsou; H Hayakawa; B Salles; C Cazaux
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

8.  Specificity of DNA lesion bypass by the yeast DNA polymerase eta.

Authors:  F Yuan; Y Zhang; D K Rajpal; X Wu; D Guo; M Wang; J S Taylor; Z Wang
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

9.  DNA polymerase beta imbalance increases apoptosis and mutagenesis induced by oxidative stress.

Authors:  M Fréchet; Y Canitrot; C Cazaux; J S Hoffmann
Journal:  FEBS Lett       Date:  2001-09-14       Impact factor: 4.124

10.  Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.

Authors:  A Vaisman; C Masutani; F Hanaoka; S G Chaney
Journal:  Biochemistry       Date:  2000-04-25       Impact factor: 3.162

View more
  6 in total

1.  Promutagenic bypass of 7,8-dihydro-8-oxoadenine by translesion synthesis DNA polymerase Dpo4.

Authors:  Hunmin Jung; Seongmin Lee
Journal:  Biochem J       Date:  2020-08-14       Impact factor: 3.857

2.  Translesion synthesis of the major nitrogen mustard-induced DNA lesion by human DNA polymerase η.

Authors:  Hunmin Jung; Naveen Kumar Rayala; Seongmin Lee
Journal:  Biochem J       Date:  2020-12-11       Impact factor: 3.857

3.  DNA interstrand cross-links induced by the major oxidative adenine lesion 7,8-dihydro-8-oxoadenine.

Authors:  Aaron L Rozelle; Young Cheun; Caroline K Vilas; Myong-Chul Koag; Seongmin Lee
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

4.  7,8-Dihydro-8-oxo-1,N6-ethenoadenine: an exclusively Hoogsteen-paired thymine mimic in DNA that induces A→T transversions in Escherichia coli.

Authors:  Andrey V Aralov; Nina Gubina; Cristina Cabrero; Vladimir B Tsvetkov; Anton V Turaev; Bogdan I Fedeles; Robert G Croy; Ekaterina A Isaakova; Denis Melnik; Svetlana Dukova; Dmitriy Y Ryazantsev; Alexei A Khrulev; Anna M Varizhuk; Carlos González; Timofei S Zatsepin; John M Essigmann
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

5.  Mutagenesis mechanism of the major oxidative adenine lesion 7,8-dihydro-8-oxoadenine.

Authors:  Myong-Chul Koag; Hunmin Jung; Seongmin Lee
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

6.  Mechanisms of telomerase inhibition by oxidized and therapeutic dNTPs.

Authors:  Samantha L Sanford; Griffin A Welfer; Bret D Freudenthal; Patricia L Opresko
Journal:  Nat Commun       Date:  2020-10-20       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.